NanoImaging Services (NIS), has opened a facility in Boston. NIS is expanding with services and locations to support its growing customer base requiring cryoEM for drug discovery and vaccine development applications.
“For more than a decade, we’ve applied our scientific leadership and focus to drive the substantial expansion of out faciltities as part of our goal to become the largest industril cryoEM facility in the world. Our Boston facility enables us to build on out commitment of advancing cryoEM technology and its access for our clients to improve and accelerate drug design and development,” said Clint Potter, CEO NanoImaging Services
“By enabling local sample preparation and screening, NanoImaging Services has eliminated one of the biggest obstacles for cryoEM researchers – shipping sensitive proteins and removing the freeze/thaw step. Local sample preparation coupled with fast turnaround screening services, allows researchers to progress their projects more quickly and with greater success in a cost-efficient manner.”
The rapid development in cryoEM technology, leading to the ‘resolution revolution’, has established cryoEM as an essential tool for structure-based drug discovery. It is allowing scientists to visualise proteins and their complexes at atomic resolutions, define target sites and design more effective medicines faster. The future impact on drug discovery – process, timeline and cost – is expected to be significant.
The new facility is designed to host clients to learn cryoEM techniques and develop their own cryoEM workflows. The dedicated lab space will house up to three Thermo Scientific Glacios Cryo-TEM microscopes and equipment to support local sample screening, preparation and analysis. In addition, a high-speed dedicated network will connect directly to the San Diego headquarters and Thermo Scientific Krios Cryo-TEM microscopes for high-resolution data acquisition. The first Glacios instrument was commissioned this month and is currently accepting client samples.
“The launch of the NanoImaging Services Boston site brings critical cryoEM capabilities to the East Coast. The site will have a significant impact and support the growing community of private companies using cryoEM as part of their drug discovery programs,” said Holly Souter, Silicon Therapeutics.
“This will be especially enabling to smaller companies that aren’t able to invest in building their own cryoEM facilities, and who can benefit from the power of this leading technology, heightened capacity and expertise within NanoImaging Services.”
